Lisinopril and Hydrochlorothiazide
- Product NDC
- 68788-8159
- 11-digit product format
- 687888159
- Labeler code
- 68788
- Product ID
- 68788-8159_cd22026d-0250-4a53-93f0-1adf4e7f966b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide Tablets
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA204058
- Marketing category
- ANDA
- Marketing start
- 2022-03-24
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68788-8159 | LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS) TABLET [PREFERRED PHARMACEUTICALS INC.] | 3 | Legacy NDC | 20240621_cd22026d-0250-4a53-93f0-1adf4e7f966b.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-8159-1 | 68788815901 | 100 TABLET in 1 BOTTLE (68788-8159-1) | 100 tablet | 2022-03-24 | 0000-00-00 | No | No | Current |
| 68788-8159-3 | 68788815903 | 30 TABLET in 1 BOTTLE (68788-8159-3) | 30 tablet | 2022-03-24 | 0000-00-00 | No | No | Current |
| 68788-8159-6 | 68788815906 | 60 TABLET in 1 BOTTLE (68788-8159-6) | 60 tablet | 2022-03-24 | 0000-00-00 | No | No | Current |
| 68788-8159-9 | 68788815909 | 90 TABLET in 1 BOTTLE (68788-8159-9) | 90 tablet | 2022-03-24 | 0000-00-00 | No | No | Current |